Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.
P/S ratio for Titan Medical Inc. (TMDI)
P/S ratio as of 2023: 0.39
According to Titan Medical Inc.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.39. At the end of 2022 the company had a P/S ratio of 0.00.
P/S ratio history for Titan Medical Inc. from 2007 to 2023
P/S ratio at the end of each year
| Year | P/S ratio |
|---|---|
| 2023 | 0.39 |
| 2022 | 0.00 |
| 2021 | 3.42 |
| 2020 | 5.71 |
| 2019 | 0.00 |
| 2018 | 0.00 |
| 2017 | 0.00 |
| 2016 | 0.00 |
| 2015 | 0.00 |
| 2014 | 0.00 |
| 2013 | 0.00 |
| 2012 | 0.00 |
| 2011 | 0.00 |
| 2010 | 0.00 |
| 2009 | 0.00 |
| 2008 | 0.00 |
| 2007 | 0.00 |